Key Record Dates
ClinicalTrials.gov Identifier: | NCT01946477 |
---|---|
Brief Title: | Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting (POM MM 014) |
First Submitted : | September 17, 2013 |
First Submitted that Met QC Criteria : | September 17, 2013 |
First Posted : | September 19, 2013 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 15, 2023 |
Last Update Posted : | May 16, 2023 |